Catherine Skari

APLASTIC ANEMIA | Incidence and Clinical Management in Spain Consistent with Other Studies

The study was carried out through a multicenter, ambispective, observational approach encompassing 7 Spanish hospitals, catering to roughly 3.91 million…

Read More »

ADVOCACY IN ACTION | Highlights from the TIF Meeting with Greek Health Minister, Adonis Georgiadis

A productive meeting between the Greek Minister of Health, Mr. Adonis Georgiades, and a Thalassaemia International Federation (TIF) delegation took…

Read More »

TIF INTERNATIONAL CONFERENCE | 3-5 November 2023

Inside the Conference The 16th International Conference on Thalassaemia and Other Haemoglobinopathies, jointly organised with the 18th TIF Conference for…

Read More »

NEW WAVE OF LEADERSHIP | WHO Appoints Regional Directors for Eastern Mediterranean, South-East Asia, and Western Pacific Regions

These influential professionals were selected by Regional Committees and confirmed by the Executive Board. Beginning their roles on 1st February…

Read More »

LentiGlobin Administration to Sickle Cell Disease Patients: Effect on Serum Markers and Vaso-Occlusive Crisis

LentiGlobin, an innovative gene therapy, introduces a modified beta-globin gene that yields an anti-sickling hemoglobin variant. It boosts total hemoglobin…

Read More »

‘Phenoconversion’ in Adult Patients with β-Thalassemia

Rate and risk factors for phenoconversion from non-transfusion-dependent β-thalassemia (NTDT) to transfusion-dependent β-thalassemia (TDT) during a 10-year follow up of…

Read More »

Pregnancy Outcomes and Iron Status in β-Thalassemia Major and Intermedia: A Systematic Review and Meta-analysis

Advancements in orally bioavailable iron chelators and MRI methods have improved life expectancy and reproductive potential in Thalassemia Major (TM)…

Read More »

A Cross-Sectional, Multicenter, Disease-Specific, Health-Related Quality of Life study in Greek Transfusion Dependent Thalassemia Patients

The assessment of Health-Related Quality of Life (HRQoL) in Thalassemia offers a holistic approach to the disease and facilitates better…

Read More »

Economic and Clinical Burden of Managing Transfusion-Dependent b-Thalassemia in the United States

Aims To describe clinical complications, treatment use, healthcare resource utilization (HCRU), and costs among patients with transfusion-dependent β-thalassemia (TDT) in…

Read More »

Erythropoiesis in Lower-risk Myelodysplastic Syndromes and Beta Thalassemia

The hematologic disorders myelodysplastic syndromes and beta-thalassemia are characterized by ineffective erythropoiesis and anemia, often managed with regular blood transfusions. Erythropoiesis, the process…

Read More »